Hepatic lipid alterations produced by doxapram.
D000315:Adrenalectomy; D000818:Animals; D000697:Central Nervous System Stimulants / Q000494:pharmacology*; D002784:Cholesterol / Q000032:analysis; D004315:Doxapram / Q000494:pharmacology; D005227:Fatty Acids / Q000097:blood / Q000378:metabolism*; D005234:Fatty Liver / Q000139:chemically induced*; D005260:Female; D005989:Glycerides / Q000097:blood* / Q000378:metabolism*; D007659:Ketones / Q000097:blood; D008099:Liver / Q000378:metabolism*; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D000697:Central Nervous System Stimulants; D005227:Fatty Acids; D005989:Glycerides; D007659:Ketones; D014280:Triglycerides; D004315:Doxapram; D002784:Cholesterol